P-SCN-Bn-DOTA

CAS No. 127985-74-4

P-SCN-Bn-DOTA( —— )

Catalog No. M35058 CAS No. 127985-74-4

p-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 126 In Stock
5MG 187 In Stock
10MG 312 In Stock
25MG 509 In Stock
50MG 726 In Stock
100MG 963 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    P-SCN-Bn-DOTA
  • Note
    Research use only, not for human use.
  • Brief Description
    p-SCN-Bn-DOTA is a chelator that simultaneously binds radionuclides and links monoclonal antibodies.
  • Description
    p-SCN-Bn-DOTA is a bifunctional chelating agent. p-SCN-Bn-DOTA can simultaneously chelate radionuclides and link monoclonal antibody for radioimmunoresearch of tumor.
  • In Vitro
    p-SCN-Bn-DOTA is complexed with 5 different metal ions: In(III), Y(III), Lu(III), Gd(III) and Cu(II).
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    127985-74-4
  • Formula Weight
    551.61
  • Molecular Formula
    C24H33N5O8S
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 20.83 mg/mL (37.76 mM; Ultrasonic (<60°C)
  • SMILES
    OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)C(Cc2ccc(cc2)N=C=S)CN(CC(O)=O)CC1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Vera DRB, et, al. Preclinical evaluation of (177)lu-nimotuzumab: a potential tool for radioimmunotherapy of epidermal growth factor receptor-overexpressing tumors. Cancer Biother Radiopharm. 2011 Jun;26(3):287-97.?
molnova catalog
related products
  • Isomaltose

    Isomaltose is a disaccharide similar to maltose, but with a α-(1-6)-linkage instead of the α-(1-4)-linkage. It is a reducing sugar.

  • Ranolazine

    Ranolazine is a calcium uptake inhibitor via the sodium/calcium channel, used to treat chronic angina.

  • PDK4-IN-1

    PDK4-IN-1 treatment significantly impedes the proliferation of human colon cancer cell lines, HCT116 and RKO.